"Adenocarcinoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant epithelial tumor with a glandular organization.
Descriptor ID |
D000230
|
MeSH Number(s) |
C04.557.470.200.025
|
Concept/Terms |
Adenocarcinoma- Adenocarcinoma
- Adenocarcinomas
- Adenoma, Malignant
- Adenomas, Malignant
- Malignant Adenoma
- Malignant Adenomas
Carcinoma, Granular Cell- Carcinoma, Granular Cell
- Carcinomas, Granular Cell
- Granular Cell Carcinoma
- Granular Cell Carcinomas
- Adenocarcinoma, Granular Cell
- Adenocarcinomas, Granular Cell
- Granular Cell Adenocarcinoma
- Granular Cell Adenocarcinomas
Adenocarcinoma, Tubular- Adenocarcinoma, Tubular
- Adenocarcinomas, Tubular
- Tubular Adenocarcinoma
- Tubular Adenocarcinomas
- Carcinoma, Tubular
- Carcinomas, Tubular
- Tubular Carcinoma
- Tubular Carcinomas
Carcinoma, Cribriform- Carcinoma, Cribriform
- Carcinomas, Cribriform
- Cribriform Carcinoma
- Cribriform Carcinomas
Adenocarcinoma, Basal Cell- Adenocarcinoma, Basal Cell
- Adenocarcinomas, Basal Cell
- Basal Cell Adenocarcinoma
- Basal Cell Adenocarcinomas
Adenocarcinoma, Oxyphilic- Adenocarcinoma, Oxyphilic
- Adenocarcinomas, Oxyphilic
- Oxyphilic Adenocarcinoma
- Oxyphilic Adenocarcinomas
|
Below are MeSH descriptors whose meaning is more general than "Adenocarcinoma".
Below are MeSH descriptors whose meaning is more specific than "Adenocarcinoma".
- Adenocarcinoma
- Adenocarcinoma in Situ
- Adenocarcinoma, Bronchiolo-Alveolar
- Adenocarcinoma, Clear Cell
- Adenocarcinoma, Follicular
- Adenocarcinoma, Mucinous
- Adenocarcinoma, Papillary
- Adenocarcinoma, Scirrhous
- Adenocarcinoma, Sebaceous
- Adrenocortical Carcinoma
- Carcinoid Tumor
- Carcinoma, Acinar Cell
- Carcinoma, Adenoid Cystic
- Carcinoma, Ductal
- Carcinoma, Endometrioid
- Carcinoma, Hepatocellular
- Carcinoma, Intraductal, Noninfiltrating
- Carcinoma, Islet Cell
- Carcinoma, Lobular
- Carcinoma, Mucoepidermoid
- Carcinoma, Neuroendocrine
- Carcinoma, Renal Cell
- Carcinoma, Signet Ring Cell
- Carcinoma, Skin Appendage
- Cholangiocarcinoma
- Choriocarcinoma
- Cystadenocarcinoma
- Eccrine Porocarcinoma
- Paget Disease, Extramammary
- Pulmonary Adenomatosis, Ovine
This graph shows the total number of publications written about "Adenocarcinoma" by people in this website by year, and whether "Adenocarcinoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 33 | 15 | 48 |
1995 | 58 | 16 | 74 |
1996 | 49 | 15 | 64 |
1997 | 39 | 15 | 54 |
1998 | 51 | 16 | 67 |
1999 | 56 | 10 | 66 |
2000 | 47 | 25 | 72 |
2001 | 55 | 10 | 65 |
2002 | 61 | 10 | 71 |
2003 | 79 | 30 | 109 |
2004 | 62 | 33 | 95 |
2005 | 102 | 35 | 137 |
2006 | 101 | 24 | 125 |
2007 | 113 | 26 | 139 |
2008 | 122 | 30 | 152 |
2009 | 113 | 28 | 141 |
2010 | 93 | 30 | 123 |
2011 | 122 | 30 | 152 |
2012 | 131 | 28 | 159 |
2013 | 122 | 30 | 152 |
2014 | 113 | 23 | 136 |
2015 | 120 | 17 | 137 |
2016 | 92 | 20 | 112 |
2017 | 110 | 17 | 127 |
2018 | 94 | 22 | 116 |
2019 | 72 | 9 | 81 |
2020 | 91 | 4 | 95 |
2021 | 62 | 8 | 70 |
2022 | 70 | 2 | 72 |
2023 | 65 | 1 | 66 |
2024 | 11 | 0 | 11 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adenocarcinoma" by people in Profiles.
-
Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer. Gut. 2024 Mar 07; 73(4):639-648.
-
ASO Visual Abstract: Serum CEA as Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment-A TAPS Consortium Study. Ann Surg Oncol. 2024 03; 31(3):1954-1955.
-
Mutant p53 protects triple-negative breast adenocarcinomas from ferroptosis in vivo. Sci Adv. 2024 Feb 16; 10(7):eadk1835.
-
Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma. JAMA Netw Open. 2024 Feb 05; 7(2):e240260.
-
Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pancreatic adenocarcinoma (CheckMate 032). J Immunother Cancer. 2024 Feb 05; 12(2).
-
Translational and oncologic significance of tertiary lymphoid structures in pancreatic adenocarcinoma. Front Immunol. 2024; 15:1324093.
-
Evidence to Date on the Therapeutic Potential of Zolbetuximab in Advanced Gastroesophageal Adenocarcinoma. Curr Oncol. 2024 Feb 01; 31(2):769-777.
-
Validation and interpretation of Pan-TRK immunohistochemistry: a practical approach and challenges with interpretation. Diagn Pathol. 2024 Jan 10; 19(1):10.
-
Hypoxia-activated prodrug and antiangiogenic therapies cooperatively treat pancreatic cancer but elicit immunosuppressive G-MDSC infiltration. JCI Insight. 2024 Jan 09; 9(1).
-
ASO Author Reflections: The Value of Serum CEA for Prognostication at Staging and Response Evaluation in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9. Ann Surg Oncol. 2024 03; 31(3):1842-1843.